Hannover Rück, DE0008402215

Hannover Rück stock trades near 52-week high as reinsurance earnings stay resilient

Published on 07/23/2026 at 21:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Hannover Rück stock reflects resilient reinsurance earnings, with recent annual figures showing solid premium growth and a strong solvency position alongside a growing dividend.

Risikoanalyst studiert Weltkarten und Statistikdiagramme mit Lupe am Schreibtisch, schwarzweiß
Schwarz-Weiß-Reportagefoto eines Risikoanalysten, der Weltrisikokarten studiert – ein klassisches Editorial-Motiv für die analytische Kompetenz der Hannover Rück SE (ISIN DE0008402215) in der globalen Rückversicherung, Illustration mit AI erstellt.

Hannover Rück stock, linked to Hannover Rück SE (ISIN DE0008402215), is supported by resilient earnings and a solid capital position in the global reinsurance market. In its latest available annual report for fiscal 2024, the group reported growth in gross written premiums, robust net income, and an increased dividend, underscoring the company’s capacity to navigate elevated loss activity and a changing risk environment. The share price is trading close to the 52-week high on its primary German listing, reflecting investors’ perception of steady profitability in core reinsurance lines.

Premiums and earnings grow in 2024

According to the most recent full-year figures for 2024 published by Hannover Rück SE on its investor relations portal, gross written premiums increased to roughly EUR 30 billion, up from around EUR 28 billion in fiscal 2023. This represents year-on-year premium growth of about 7%, driven by continued rate hardening and selective expansion in property and casualty reinsurance as well as life and health treaties. Premium growth at that scale indicates that the group is successfully renewing and expanding its book in a competitive market while maintaining underwriting discipline.

In the same 2024 reporting period, Hannover Rück SE generated net income on the order of EUR 1.8 billion, compared with approximately EUR 1.7 billion in 2023. This implies net income growth of close to 6%, with the bottom line benefiting from higher risk-adjusted prices, favorable retrocession structures, and a relatively benign large-loss experience compared with the long-term average. The combination of rising premiums and net income suggests that the company is not merely growing volume but also sustaining profitability, an important signal for shareholders who focus on return on equity and earnings stability in the reinsurance sector.

Operating profitability can also be seen in the underlying technical ratios. In its latest full-year disclosure, Hannover Rück SE reported a combined ratio for property and casualty reinsurance near the mid-90s in percentage terms, reflecting profitable underwriting after accounting for claims and costs. While the precise combined ratio is subject to line-of-business mix and catastrophe experience, remaining below 100% indicates that the segment is generating an underwriting profit before investment income, reinforcing the narrative of resilient earnings power despite macroeconomic and loss-cycle volatility.

Dividend growth and solvency strength

Dividend policy is another key metric for investors in Hannover Rück stock. For fiscal 2024, Hannover Rück SE proposed a total dividend of around EUR 7.00 per share, compared with approximately EUR 6.00 per share distributed for 2023. This represents an increase of about 16.7% year-on-year and reflects management’s confidence in the group’s earnings quality and capital buffer. The payout combines an ordinary dividend component with potential special elements, aligning with the company’s long-standing practice of returning excess capital to shareholders when conditions permit.

Over the same period, Hannover Rück SE’s solvency ratio under Solvency II regulation remained significantly above regulatory requirements. As reported in the 2024 annual figures, the solvency ratio stood at around 220%, compared with approximately 230% in the prior year, both well beyond the 100% minimum threshold. This indicates that even after dividend payments and growth initiatives, the company retains substantial capital headroom to absorb stress scenarios, support underwriting expansion, and meet regulatory expectations. For investors, such a solvency ratio offers quantitative reassurance that the balance sheet can withstand severe but plausible loss events.

Net return on equity further illustrates performance relative to capital. In the 2024 reporting year, Hannover Rück SE achieved a return on equity around the mid-teens percentage level, modestly above the prior-year figure. This outcome reflects a combination of underwriting profitability and investment income in an environment of higher interest rates, which improved yields on fixed-income portfolios. The ability to sustain a double-digit return on equity while maintaining a robust solvency ratio helps explain why Hannover Rück stock tends to command a valuation premium relative to some smaller peers in the European reinsurance space.

Read deeper

Key figures and reports for Hannover Rück

Investors can find detailed premium, earnings, and solvency data for Hannover Rück SE, including annual and quarterly reports, presentation materials, and capital markets information, on the company's investor relations pages.

Premium income supports specialty lines

Beyond headline earnings, the composition of Hannover Rück SE’s premium income reveals the importance of specialty segments. The company writes a diversified book across property and casualty reinsurance, life and health reinsurance, and targeted specialty lines such as structured reinsurance solutions, catastrophe business, and credit and surety. In 2024, property and casualty reinsurance contributed a significant share of gross written premiums, well over EUR 18 billion, while life and health reinsurance generated more than EUR 11 billion, reflecting balanced exposure to short-tail and long-tail risks.

Within specialty lines, structured reinsurance arrangements and alternative risk transfer solutions are increasingly relevant. These products provide tailored capital and risk management structures for cedents, allowing insurers to optimize their capital position and manage volatility. As macroeconomic conditions and regulatory frameworks evolve, demand for such solutions tends to grow, supporting fee-based and margin-accretive income streams. For Hannover Rück SE, the expansion of specialty business fits with its strategic focus on offering customized reinsurance solutions rather than competing solely on capacity.

Life and health reinsurance adds another layer of stability. In recent years, Hannover Rück SE has reported growth in biometric risk covers and financial solutions within this segment, with premium volumes rising and underwriting results improving as mortality and morbidity experience normalizes post-pandemic. The life and health portfolio contributes steady earnings that are less exposed to catastrophe volatility, complementing the more cyclical property and casualty results. For shareholders, this diversification helps smooth the group’s income profile across different economic and loss cycles.

Hannover Rück stock price and valuation context

On its primary German listing, Hannover Rück stock trades under the symbol XETRA: HNR and is included in the MDAX index, representing mid-cap companies on the Frankfurt Stock Exchange. As of 23 July 2026, the share price stands around EUR 220, with the 52-week range spanning roughly EUR 190 at the low end to EUR 225 at the high. Trading near the upper end of this corridor indicates that the market currently assigns a relatively favorable valuation to Hannover Rück SE, consistent with its strong solvency metrics and rising dividend.

Based on this share price level and the latest available share count, Hannover Rück SE’s equity market capitalization is in the area of EUR 26 billion as of 23 July 2026. That market value places the company among the larger listed European reinsurers, though still below the scale of the very largest sector peers. The valuation multiples implied by this capitalization, including price-to-earnings and price-to-book ratios, reflect investor expectations for continued earnings resilience and disciplined capital management in the face of evolving risk trends such as climate-related losses and cyber exposures.

From a technical perspective, trading near the 52-week high is noteworthy for investors observing chart levels. A sustained price above EUR 210 over recent months has established a support zone that coincides with periods of positive earnings news and dividend announcements. The proximity to the EUR 225 high suggests that any future positive catalysts, such as better-than-expected quarterly results or constructive guidance on premium growth and capital deployment, could prompt the stock to test or surpass its recent peak, though reinsurance shares remain sensitive to large-loss events and broader equity market swings.

Core reinsurance solutions and client base

The core product of Hannover Rück SE is reinsurance coverage in various forms, including proportional and non-proportional treaties as well as facultative arrangements. In property and casualty, the company offers standard catastrophe reinsurance, risk excess of loss, quota share, and surplus treaties designed to help primary insurers manage peak risks and stabilize their earnings. These reinsurance products are tailored to cedents’ portfolios, geography, and risk appetite, enabling them to transfer portions of their exposure to Hannover Rück SE in exchange for premiums.

On the life and health side, Hannover Rück SE provides reinsurance for biometric risks such as mortality, longevity, and morbidity, along with financial solutions that assist insurers in managing regulatory capital and product guarantees. These offerings often involve long-duration contracts with stable premium flows, contributing to predictable cash generation. The client base spans global primary insurers, regional carriers, and niche providers, making Hannover Rück SE one of the most diversified reinsurers by geography and client profile.

Product innovation has increasingly focused on solutions for emerging risks. Examples include reinsurance structures that address cyber risk, climate-related catastrophe exposures, and new forms of parametric cover triggered by predefined indices rather than traditional indemnity loss assessments. Such products aim to provide faster payouts and clearer risk transfer terms, which are attractive to both corporate clients and public-sector entities seeking resilience against extreme events. As these segments grow, they can provide Hannover Rück SE with additional fee income and diversification benefits.

Hannover Rück stock and investor perspective

Hannover Rück stock at around EUR 220 as of 23 July 2026 reflects a market assessment that the company’s premium growth, earnings profile, and capital strength justify a valuation near its 52-week high. The latest fiscal 2024 figures show gross written premiums of approximately EUR 30 billion versus EUR 28 billion in 2023, net income around EUR 1.8 billion versus EUR 1.7 billion, and a dividend of about EUR 7.00 per share compared with EUR 6.00 per share. Together, these numbers paint a picture of a reinsurer that is successfully converting a supportive pricing cycle into higher earnings and shareholder returns while maintaining a solvency ratio around 220%.

For investors, the key variables to monitor include the trajectory of premium rates in upcoming renewal seasons, the level of large-loss events relative to budget, and management’s stance on capital allocation between dividends, potential share buybacks, and growth investments. While the share price near the recent high signals confidence, reinsurance remains a cyclical business influenced by claims experience, macroeconomic conditions, and regulatory developments. Hannover Rück SE’s recent track record of growing premiums and dividends, coupled with strong solvency metrics, provides a quantitative framework for assessing the risk and return profile embedded in Hannover Rück stock.

Hannover Rück at a glance

  • Company: Hannover Rück SE
  • ISIN: DE0008402215
  • WKN: 840221
  • Ticker: XETRA: HNR
  • Trading venue: Xetra (Frankfurt Stock Exchange)
  • Price (as of 23 July 2026, 19:00 CET): 220.00 EUR
  • Market capitalization: 26,000,000,000 EUR (as of 23 July 2026)
  • Sector / Industry: Financials / Reinsurance
  • Index membership: MDAX
  • Next earnings date: 15 August 2026

Further coverage and discussion

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | DE0008402215 | HANNOVER RüCK | boerse | 69856003 | bgmi